Abstract

Non-small cell lung cancer (NSCLC) is one of the most common lung cancers, accounting for more than 85% of lung cancer incidence rates and seriously endangering human health. Increasing evidence shows that some long non-coding RNAs (lncRNAs) act as tumor suppressors and some promote cancer. Pterostilbene-regulated lncRNA-linc00511 has been confirmed to be an oncogenic gene in a variety of tumors. This study aimed to determine the biological function of pterostilbene-regulated lncRNA-linc00511 (LINC00511) in non-small cell lung cancer and provide new diagnostic and therapeutic targets for it. Lung cancer A549 cells were randomly divided into control group and hypoxic group. siRNA knockdown and LINC00511 overexpression plasmid were constructed under hypoxic conditions. Pterostilbene was used to intervene with lncRNA-linc00511. Real time PCR was used to detect the expression changes of LINC00511 and MiR-184. Analyze and detect the effect on the proliferation and invasion of non-small cell lung cancer cells under hypoxic conditions. Real time PCR analysis was used to detect the expression changes of EMT molecules E-cadherin and Vimentin. Western blot detected changes in HIF-1α expression. The expression of LINC00511 increased and the expression of MiR-184 decreased in lung cancer A549 cells, and hypoxic environment led to more significant changes in both. After siRNA knocked down the expression of LINC00511 under hypoxic conditions, pterostilbene was used to intervene with lncRNA-linc00511. The results showed that it promoted the expression of MiR-184, inhibited the proliferation and invasion of lung cancer cells, upregulated the expression of EMT molecules E-cadherin, and increased the expression of Vimentin. The expression is reduced and the expression of HIF-1α is downregulated. Overexpression of LINC00511 can reverse the above changes. Under hypoxic conditions, pterostilbene was used to interfere with lncRNA-linc00511 to promote cell proliferation in non-small cell lung cancer cells. Pterostilbene’s intervention with lncRNA-linc00511 could target the expression of MiR-184 to promote the proliferation and invasion of non-small cell lung cancer. Knocking down the expression of LINC00511 can target down-regulate the expression of MiR-184, change the occurrence of EMT, and alleviate the occurrence and progression of non-small cell lung cancer.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.